Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
5509 studies found for:    Solid Tumors
Show Display Options
Rank Status Study
1 Completed Genetic Investigation of Solid Tumors Cohort
Conditions: Prostate Cancer;   Colon Cancer
Intervention:
2 Completed Dose-Escalation Phase 1 Study of G-202 (Mipsagargin) in Patients With Advanced Solid Tumors
Condition: Advanced Solid Tumors
Intervention: Drug: G-202
3 Active, not recruiting Sorafenib and Bevacizumab in Combination With Paclitaxel in Patients With Solid Tumors
Condition: SOLID TUMORS
Intervention: Drug: Sorafenib
4 Active, not recruiting A Cardiac Safety Study of TH-302 in Patients With Advanced Solid Tumors
Condition: Solid Tumors
Intervention: Drug: TH-302
5 Active, not recruiting A Dose Escalation Study of SCB01A in Subjects With Advanced Solid Tumors Who Have Failed Standard Therapy
Condition: Solid Tumors
Intervention: Drug: SCB01A
6 Not yet recruiting MASCT-I Treatment for Advanced Solid Tumor
Condition: Solid Tumors
Intervention: Biological: MASCT-I
7 Completed A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally Daily to Subjects With Solid Tumors
Condition: Solid Tumours
Intervention: Drug: GSK1363089 (formerly XL880)
8 Completed A Phase I Trial of Nelfinavir (Viracept ) in Adults With Solid Tumors
Condition: Solid Tumors
Interventions: Drug: Nelfinavir;   Drug: Nelfinavir Mesylate
9 Completed To Evaluate the Safety of Veliparib in Combination With Temozolomide in Subjects With Solid Tumors
Condition: Solid Tumor Cancers
Interventions: Drug: veliparib;   Drug: Temozolomide
10 Recruiting A Trial of Dasatinib (PDGFR and SRC Inhibitor), Temsirolimus and Cyclophosphamide in Patients With Advanced Solid Tumors
Condition: Solid Tumors
Interventions: Drug: Dasatinib;   Drug: Cyclophosphamide;   Drug: Temsirolimus
11 Completed Safety Study to Evaluate KW-2450 in Subjects With Advanced Solid Tumor
Condition: Solid Tumor
Intervention: Drug: KW-2450
12 Completed Phase I Study of IPI-504 and Docetaxel in Patients With Advanced Solid Tumors
Condition: Solid Tumors
Intervention: Drug: IPI-504, docetaxel
13 Completed To Determine the Maximum Tolerated Dose of Oral CEP-37440 in Patients With Advanced or Metastatic Solid Tumors
Condition: Solid Tumors
Intervention: Drug: CEP-37440
14 Completed Interest of Routine Screening for Hepatitis B and C in Patients Receiving Chemotherapy for Solid Tumors
Condition: Solid Tumor
Intervention: Other: hepatitis B virus (HBV) and hepatitis C virus (HCV) serologies and a screening questionnaire to detect risk factors of hepatitis B virus (HBV) and hepatitis C virus (HCV)
15 Recruiting Trial of Intratumoral Administration of Recombinant Vesicular Stomatitis Virus in Patients With Refractory Solid Tumors
Condition: Malignant Solid Tumour
Intervention: Biological: VSV-IFNβ-NIS
16 Completed A Phase 1 Dose Escalation Study of OMP-21M18 in Subjects With Solid Tumors
Condition: Solid Tumors
Intervention: Drug: OMP-21M18
17 Completed
Has Results
An Open Label Phase I Dose Escalation Study of E7080 Administered to Patients With Solid Tumors
Condition: Cancer: Solid Tumors
Intervention: Drug: E7080
18 Completed A Phase I Study of Bi-Weekly rBBX-01 in Patients With Solid Tumors
Condition: Solid Tumors
Intervention: Biological: rBBX-01
19 Recruiting Study of Regorafenib and Sildenafil for Advanced Solid Tumors
Condition: Solid Tumor
Interventions: Drug: Regorafenib;   Drug: Sildenafil Citrate
20 Completed Temsirolimus and Pazopanib in Patients With Advanced Solid Tumors
Condition: Solid Tumors
Intervention: Drug: Temsirolimus, Pazopanib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.